Ibu-Lysin (Ibuprofen)

Ibuprofen blocks the activity of cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, preventing the formation of prostaglandins that mediate inflammation, pain, and fever. By lowering prostaglandin levels, ibuprofen reduces swelling, alleviates pain signals, and helps normalize body temperature.

The appropriate dose of Ibu-Lysin is determined by the prescribing healthcare professional based on the patient's age, weight, clinical condition, and response to therapy. Dosage instructions are provided on the prescription label and should be followed exactly as directed.

Use of ibuprofen during pregnancy, especially in the third trimester, is generally discouraged due to potential risks to the fetus. While limited data exist for breastfeeding, ibuprofen is excreted in small amounts in breast milk. Women who are pregnant or nursing should consult their physician before using Ibu-Lysin.

To place an order, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Ibu-Lysin (ibuprofen) offers a balanced profile of analgesic, antipyretic, and anti‑inflammatory effects with a relatively short half‑life, allowing flexible dosing. Compared with stronger NSAIDs like diclofenac, ibuprofen generally has a lower risk of gastrointestinal ulceration but may be less potent for severe inflammatory arthritis. Choice of NSAID depends on individual risk factors and therapeutic goals.

Store Ibu-Lysin tablets at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, heat, and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Ibu-Lysin is taken orally, usually with a full glass of water. It can be taken with or without food; however, taking it with food may reduce the likelihood of gastrointestinal discomfort. Swallow the tablet whole; do not crush or chew unless specifically instructed by a healthcare professional.

Serious risks include gastrointestinal bleeding or ulceration, cardiovascular events such as heart attack or stroke, severe allergic reactions (including anaphylaxis), and renal impairment. Patients with a history of ulcer disease, cardiovascular disease, or kidney dysfunction should be closely monitored and discuss alternative therapies with their physician.

Ibu-Lysin should be avoided in individuals with known hypersensitivity to ibuprofen or other NSAIDs, active peptic ulcer disease, severe heart failure, uncontrolled hypertension, or significant renal or hepatic impairment. Pregnant women in the third trimester and patients on anticoagulant therapy should also consult a physician before use.